The ASX microcap whose biggest contract is worth almost as much as the company

Synertec (ASX: SOP) is still priced for its past. Here's what it could earn by FY28, what I think it's worth, and what could go wrong.
Naheed Rahman

RaaS Research Group

In September, Synertec Corporation (ASX: SOP) signed a $45.5m contract with the Australian Nuclear Science and Technology Organisation (ANSTO). At 9.1c/s, the market values the whole company at $58.3m, which is less than the $74.3m of contracted work Synertec now has in hand.

The stock is pretty undiscovered going by institutional ownership and broker coverage, and as I see it, that gap is the opportunity. The market still prices Synertec for its past: losses, a thin balance sheet, and a share price that touched 1.8c/s in the past year. Even after bouncing from 6.8c/s two weeks ago, the shares sit below the 11c/s they reached after September's guidance upgrade. It isn't yet pricing the contracted business Synertec has become, nor the large pipeline that it has in place from which it should win significant work.

The thesis in three points

  • Visibility that's rare for a microcap. FY27 revenue guidance is $37.5–40.0m, and the company says it is ‘100% contracted’.
  • Engineering has stepped up a division. The ANSTO contract is worth 2.4x last year's Engineering revenue.
  • FY28 is when the earnings show up. On my forecasts, Synertec trades on about 8x FY28 earnings. Listed engineering peers trade on about 19–22x.

When guidance is fully contracted

When I look at a microcap's growth story, I separate three numbers. The pipeline is what a company hopes to win. Work-in-hand is what it has signed. Guidance is what management will be judged on.

Most small companies lead with the pipeline. The moment I find interesting is when guidance is fully covered by signed work. At that point, the risk shifts from winning work to delivering it, and markets are often slow to notice, particularly when a stock has a weak history.

Synertec reached that point in October. Contracted work-in-hand is $74.3m, about five times what it was a year ago (Exhibit 2). Guidance was lifted in September from $29.5–31.7m to $37.5–40.0m. It was reaffirmed on 30 October at the company’s September 2026 quarterly Trading and Business Update (Exhibit 1).

Exhibit 1: FY27 revenue guidance upgraded and now ‘100% contracted’

Source: Synertec FY26 Appendix 4E (31 Aug 2026); 4Q FY26 4C (30 Jul 2026); Guidance Upgrade (23 Sep 2026); FY27 1Q 4C and Trading and Business Update (30 Oct 2026). FY25 implied from FY26 revenue of $21.1m, up 19%. Hatched area = guidance range.

Exhibit 2: Contracted work-in-hand is about 5x a year ago

Source: Synertec FY27 1Q 4C and Trading and Business Update (30 Oct 2026). Split not disclosed for earlier periods. *The finance section gives Engineering as ~$59m; the MD’s commentary says ~$54m. Work-in-hand spans more than one year (ANSTO runs to ~FY35).

What Synertec does

Synertec has two divisions:

Engineering – designs and integrates process, automation and control systems for water utilities, energy companies and life sciences. Its clients include Melbourne Water, AGL and most recently ANSTO.

Technology – Powerhouse is Synertec's own technology: an AI-enabled, renewable, battery-based microgrid for remote industrial sites such as gas wells. Customers either buy units or rent them under a build, own, operate and maintain (BOOM) model. Powerhouse is essentially a self-contained power station that never needs diesel delivery.

At a high level, the way I think about it is that Engineering is the cash cow, and Powerhouse is the valuation of the business.

What's changed, and what the market is missing

Powerhouse is becoming a repeat-order platform.

Powerhouse is the business that first got my attention in mid-2026. After several years of R&D and working with energy company Santos (ASX: STO) to develop Powerhouse, Synertec was finally at the commercialisation stage. What has followed in the past 12 months is a major proof point, with sales of Powerhouse to major customers such as Santos, Shell, Amplitude Energy and TasNetworks.

Santos runs six units across its GLNG operations. In September, it also bought a 12MW system for Moomba worth about $6m, 10 to 60x the size of previous units. Repeat orders from a major are the best due diligence a microcap can get.

Shell QGC has rented a unit, TasNetworks has ordered six community batteries, and Amplitude Energy has named Powerhouse its preferred solution at Orbost. The fleet has delivered better than 99.95% availability over six years.

Those six Santos GLNG units are expected to power only 20–25 coal seam gas wells. Santos' 2025 GLNG plan describes the project as including 2,650 production wells across Roma, Fairview and Arcadia Valley. Shell said in November 2026 that QGC, where Synertec has one trial unit, operates around 3,500 production wells and 25 compression stations. The Surat region had more than 11,000 CSG wells producing or completed at the end of 2024, and official projections see that total rising to 21,000 over the life of the industry. Each well site, or a cluster of them, is the type of remote load Powerhouse is built to serve. There is a long runway for growth that should last several years.

Exhibit 3 shows Powerhouse’s four market segments that are addressable. The value of the Powerhouse pipeline continues to grow and currently sits at ~$500m, equating to ~1.2GWh of storage capacity.

Exhibit 3: Powerhouse market engagement segmentation

Source: Synertec FY26 Results Presentation

Engineering has stepped up a division

ANSTO chose Synertec to lead process design on its Nuclear Medicine Manufacturing Program at Lucas Heights, with the contract worth $45.5m over an eight-year program. The company expects about $36m of this revenue over the first 26-month design phase, at a contribution margin above 25%.

Spread evenly, that's about $4m a quarter, roughly 70% of the group's entire September-quarter revenue. The contract is also cumulatively cash-flow positive for more than 90% of its term, which matters for a microcap.

In my view, the credential is worth as much as the cash, because it should be a strong reference point for further healthcare, nuclear and critical-infrastructure work. Currently, the Engineering pipeline of qualified opportunities sits at $157m (down from the $174m at the FY26 result, partly as ANSTO converted to contracted work).

The turnaround is already in the numbers

  • Group EBITDA improved from -$5.8m in FY25 to -$1.9m in FY26.
  • Operating cash flow swung from -$4.1m to +$0.5m.
  • $1.5m came out of corporate costs, and EBITDA broke even in September 2026.

Exhibit 4 from Synertec’s FY26 results presentation captures it best. With the company on a much better financial footing, recent wins and the growing pipeline bode well for future periods.

Exhibit 4: Financial performance highlights

Source: Synertec FY26 Results Presentation

Why I value Synertec on FY28, not FY27

Valuing a turnaround on the year it is still turning around undersells it. FY27 is a transition year financially, as the company moves from loss-making into profitability. FY28 is the first year that shows what the contracted work earns at full speed.

  • ANSTO only started on 21 September 2026. FY27 gets about nine months of the design phase; FY28 is the first full year.
  • Powerhouse deliveries land late in FY27 and into FY28. Eleven units, worth about $20m, are due within 15 months, including Moomba by 30 September 2027.
  • The rental base compounds. Recurring Powerhouse revenue rose 23% to $2.5m in FY26, and rental units earn an EBITDA margin of ‘circa 90%’ as cited by the company. Each unit delivered in FY27 earns a full year in FY28.
  • The order book runs well beyond one year. Work-in-hand is about twice FY27 guidance, with a $157m Engineering pipeline and ~$500m of Powerhouse opportunities behind it.
  • FY27 carries ramp-up costs. First-quarter cash flow absorbed $1.1m of timing items, including ANSTO mobilisation. They shouldn't recur.

Valuation: FY28 is where the maths gets interesting

These forecasts come from my own model. They are not company guidance; Synertec guides revenue only, and only for FY27.

Exhibit 5: Forecast estimates

Source: Author's estimates. My forecasts assume no tax (Synertec has accumulated tax losses) and use 640.2m shares. EV = $58.3m market cap + $8.2m debt − $4.2m cash at 30 September.

On FY27, the stock isn't cheap. On FY28, it's a different company. Listed engineering peers (Lycopodium, Duratec, IPD Group and Verbrec) trade on about 19–22x trailing earnings (Markit, 13 November 2026).

I use 15x, about a quarter below that range, for size, liquidity and balance-sheet risk. On 1.1c of FY28 EPS, that gives 16.4c/s, or 1.8x today's price.

The downside. There's no asset floor: net assets were just $0.9m at 30 June. If the market valued FY27 revenue at the lowest peer multiple (0.8x, Exhibit 6), the shares would be worth about 4.2c/s, or 54% lower.

Exhibit 6: At 1.6x FY27 guidance, SOP’s EV/revenue sits within the peer range of 0.8–2.0x

Source: Markit Digital ASX key statistics (13 Nov 2026) for peers, on trailing reported revenue (VBC FY25, others FY26). SOP EV is the author’s build: $58.3m market cap + $8.2m Altor debt drawn − $4.2m cash (30 Sep 2026) = ~$62.3m; excludes leases. Peers are trailing, SOP forward.

The catch. These are two-year forecasts for a company that has never made an annual profit. FY28 needs ANSTO on schedule, Powerhouse units delivered on time and the pipeline converting, which is why I use below-peer multiples. If FY27 slips, FY28 slips with it.

Why now

  • 26 November 2026: AGM. A chance for a trading update.
  • December 2026: Amplitude's investment decision on Orbost.
  • Late January 2027: December-quarter report. It will be the first full quarter of ANSTO revenue.
  • Late February 2027: 1H FY27 result. Commentary on the half delivered and detailed half-year financials.
  • Mid-2027: Santos GLNG units #5 and #6. By 30 September 2027: Moomba.

Playing devil's advocate

Can they hit a back-ended number? First-quarter revenue was $5.9m, so the remaining quarters need about $10.5–11.4m each, nearly double the current rate. ANSTO covers a large part of the gap, but the year depends on ANSTO and Powerhouse ramping up on time.

Is the balance sheet strong enough? At 30 June, net current liabilities were $5.8m, while available funding is about $12.9m (Exhibit 7) and the Altor debt costs 12–14%. Rental Powerhouse units tie up capital, so I’d expect more raisings if BOOM scales. The August placement at 5c/s shows how that can look.

Exhibit 7: Funding position: ~$12.9m available, $8.2m of Altor debt

Source: Synertec FY27 1Q 4C (30 Oct 2026). Total financing facilities $17.37m, of which $8.65m drawn. Altor priced at 3-month BBSY + 9% (BBSY floored at 3.00%, capped at 5.35%); 24-month principal holiday, then 30% amortisation and 70% balloon.

Is it too concentrated? ANSTO is the bulk of the Engineering order book, and Santos dominates Powerhouse. Contract timing is likely to be lumpy.

Overhang and liquidity? Altor holds 23.4m warrants, and Regal cut its stake from 11.4% to 9.9% in September. The stock trades about $200,000 a day.

Final word

Synertec has moved from ‘show me’ to ‘deliver’. Its guidance is contracted, and on my FY28 numbers you're paying about 8x earnings for a business whose contracted work is only now ramping up. There is a long runway for growth that should last several years, and it seems that the stock may potentially be entering an earnings upgrade cycle.

There are certainly risks involved, particularly a clear miss on the first-half run rate, and a material delay at ANSTO or Moomba. However, the company has demonstrated much tighter operational and financial discipline, particularly since CFO Yash Gala commenced in the role in late 2024; my strongest sense from several meetings with management since the middle of this year is that they are running this business to optimise for margins and returns.

With Engineering profitable, contributing cash and growing, Powerhouse looks well timed: the R&D is largely done, and commercialisation is starting with large Tier 1 customers. There is a long pipeline to work through.

........
• Holdings: The author, Naheed Rahman, holds shares in Synertec Corporation (ASX: SOP). • Relationship: Synertec is not a client of RaaS Research Group. RaaS has not been paid for this article or for any research on Synertec. • Basis: I am writing in a personal capacity, and the views expressed are my own. They are based on Synertec's ASX announcements and other publicly available information. I am not disclosing any confidential or non-public information. • General advice only: This wire contains general information only. It does not take into account your objectives, financial situation or needs, and it is not a recommendation to buy or sell any security. Past performance is not a reliable indicator of future performance. Consider seeking personal financial advice before making any investment decision.

1 stock mentioned

Naheed Rahman
Investor
RaaS Research Group

Naheed is an investment professional focused on Australian microcap equities. Naheed's background spans equity research and portfolio management. He currently researches and invests in ASX-listed microcap stocks through roles at Cygnet Capital...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment